Pataky, Reka E. https://orcid.org/0000-0003-0159-582X
Bryan, Stirling https://orcid.org/0000-0001-7093-3058
Sadatsafavi, Mohsen https://orcid.org/0000-0002-0419-7862
Peacock, Stuart https://orcid.org/0000-0002-8243-8721
Regier, Dean A. https://orcid.org/0000-0001-8876-0511
Funding for this research was provided by:
Canadian Institutes of Health Research (FRN 140372)
Canadian Cancer Society
Genome Canada (G05CHS)
Article History
Accepted: 14 September 2023
First Online: 11 October 2023
Declarations
:
: REP was supported by a Canadian Institute of Health Research Doctoral Research Award. The Canadian Centre for Applied Research in Cancer Control is funded by the Canadian Cancer Society. The Canadian Network for Learning Healthcare Systems and Cost-effective ‘Omics Innovation (CLEO) is supported by Genome BC/Genome Canada [G05CHS].
: DAR’s institution has received research grants from Roche. REP, MS, SB and SP declare that they have no conflict of interest.
: This research was conducted under an approval from the University of British Columbia – BC Cancer Research Ethics Board, certificate H15-03418.
: This study uses linked administrative data from BC Cancer and the BC Ministry of Health, requested and accessed through Population Data BC. Access to data provided by the Data Steward(s) is subject to approval but can be requested for research projects through the Data Steward(s) or their designated service providers. All inferences, opinions, and conclusions drawn in this publication are those of the author(s), and do not reflect the opinions or policies of the Data Steward(s).
: Not applicable.
: Not applicable.
: Not applicable.
: REP and DAR developed the research question and study design, and all authors provided feedback on the study design and analysis plan. REP was responsible for data acquisition and analysis. All authors contributed to the review and interpretation of results. REP drafted the manuscript, and all authors provided critical revision and final approval.